Geoffrey W. Krystal

Oncology
1201 Broad Rock Blvd
Richmond, VA 23249

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications

Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression.

Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 05, 2017

Auer Rods.

Auer Rods.

Journal: The New England journal of medicine
Published: May 25, 2017

Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer.

Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer.

Journal: Cancer biology & therapy
Published: November 18, 2015

Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo.

Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo.

Journal: Oncotarget
Published: October 31, 2014

Early FDG/PET scanning as a pharmacodynamic marker of anti-EGFR antibody activity in colorectal cancer.

Early FDG/PET scanning as a pharmacodynamic marker of anti-EGFR antibody activity in colorectal cancer.

Journal: Molecular cancer therapeutics
Published: May 08, 2012

Teaching an old drug new tricks: Actinomycin D synergistically enhances sensitivity to the Bcl-2 antagonist ABT-737.

Teaching an old drug new tricks: Actinomycin D synergistically enhances sensitivity to the Bcl-2 antagonist ABT-737.

Journal: Cancer biology & therapy
Published: October 12, 2010
Showing 1-6 of 6

Last Updated: 09/26/2026